Depressive symptoms and myeloproliferative neoplasms: Understanding the confounding factor in a complex condition.

Leslie J PadrnosRobyn ScherberHolly GeyerBlake T LanglaisAmylou C DueckHeidi E KosiorekZhenya SenyakMatthew M ClarkMichael BoxerMary CotterClaire HarrisonCynthia StonningtonYonas GedaRuben Mesa

Published in: Cancer medicine (2020)

This analysis suggests the importance of depression in contributing to as well as confounding symptomatology in MPN patients, and suggests that this critical variable should also be addressed by clinicians and researchers alike when comprehensively assessing symptom burden etiologies.

Keyphrases

depressive symptoms
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
sleep quality
palliative care
prognostic factors
social support
patient reported outcomes
physical activity